close

Fenwick Represents Evidation in $30 Million Series C Financing

August 01, 2018

​​Fenwick & West represented Evidation Health, Inc., a leading health and measurement company that helps life sciences companies and health care companies understand how everyday behaviors and health interact, in its $30 million Series C financing. SV Health Investors, a new investor, and existing investor B Capital Group co-led the round with participation from existing investors GE Ventures and Sanofi Ventures.

Evidation also announced that it launched a new data platform to enable its customers to analyze and process large-scale sensor and behavior data in clinically meaningful ways. In addition to supporting the new data platform, the financing will be used to develop partnerships to add to Evidation’s vast array of real world data sources, and launch novel research studies to better understand and measure how everyday behavior and health interact. More information about Evidation’s $30 million Series C financing can be obtained from the company announcement.

The Fenwick transaction team was led by corporate lawyers Michael Esquivel, Kristine Di Bacco, Ryan McRobert and Noah Johnson.